| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |